Entries by michelle hall

CoreRx, Inc. announces that its client Bionpharma has received FDA approval for a generic version of ONFI® (Clobazam)

Clearwater, Florida- November 4, 2018 – CoreRx, Inc. announces that its client Bionpharma has received FDA approval for a generic version of ONFI® (Clobazam) Oral Suspension, 2.5mg/mL.  Clobazam Oral Suspension is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.  CoreRx developed the formulation […]

Installation of the Optel Line Master Serialization and Aggregation

Clearwater, Florida – As part of CoreRx, Inc’s growth in expanding its cGMP manufacturing capabilities to support niche commercial products, we are pleased to announce the completed installation of the Optel Line Master Serialization and Aggregation System for support of commercial liquid dosage form manufacturing.  In addition to handling serialization, which the FDA has mandated for commercial […]

Bionpharma Signs Drug Product Manufacturing Contract with CoreRx

Bionpharma Signs Drug Product Manufacturing Contract with CoreRx to Formulate and Manufacture Generic Pharmaceuticals PRINCETON, NJ and Tampa, FL – July 30, 2018. Bionpharma, a global biopharmaceutical company, is pleased to report the Company has signed a Definitive Agreement with CoreRx, a leading Contract Development Manufacturing Organization (CDMO), for the development and manufacturing of a […]

Contract with Innovation Pharmaceuticals to formulate Sachets

Innovation Pharmaceuticals Signs Drug Product Manufacturing Contract with CoreRx to Formulate and Package Brilacidin for Oral Mucositis in Sachet Form Brilacidin BEVERLY, MA – July 17, 2018 (GLOBE NEWSWIRE) Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report the Company has signed a Drug Product manufacturing contract with CoreRx, a leading Contract […]